FDA approves first absorbable stent for coronary artery disease - FDA Press Releases

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases the drug everolimus to limit the growth of scar tissue, is gradually absorbed by the body in approximately three years.

from Food and Drug Administration--Press Releases http://ift.tt/29tBu8D
via IFTTT